Molecule Details
| InChIKey | RHDRZFXISWDZNM-FGQYDPOTSA-N |
|---|---|
| Compound Name | (4R,7S,10S,13R,16S,19R)-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-24-ethynyl-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-2-thia-5,8,11,14,17,20-hexazabicyclo[20.4.0]hexacosa-1(22),23,25-triene-4-carboxamide |
| Canonical SMILES | C#Cc1ccc2c(c1)C(=O)N[C@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@H](C(N)=O)CS2 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.23 |
| Source | ChEMBL |
2D Structure
Activity Profile